Breast Cancer [BC]

From @Point of Care

Разработчик: @Point of Care
Скачивания
Доход

Описание

Breast Cancer @Point of Care for clinicians provides a well-engineered clinical decision support tool for you to obtain timely medical content and news as well as earning CME/CE credits, completely free of charge. If used in conjunction with our PRO Patient line of apps for patients (35+ apps for major conditions), Suite can provide you meaningful insights into between-visit patient progress—driving better decisions, better outcomes, and better care.
The app features Ask Cognitive™, an AI-assisted search technology to easily access curated, evidence-based, and disease-specific medical content. Clinicians can navigate content by asking voice-enabled natural language questions or typing them in. The Ask Cognitive confidence-rated answers efficiently incorporate the best current treatment options so decisions can be reached confidently and more rapidly, helping to improve patient outcomes. Answers can also be further investigated for deeper dives.
Features:
• Continually updated breast cancer content from expert physician authors
• Customize library with over 50 therapeutic areas to choose from
• Topics in diagnosis, treatment, and care management
• Case studies, videos, and interviews
• Access to actionable patient-recorded data
• Detailed reference list with access to original sources
• Continuing medical education credit (CME/CE) free of charge
• Surveys and peer polling
• Patient education resources to share with patients
Breast Cancer @Point of CareTM is designed to:
• Support discovery and practice change
• Provide relevant, evidence-based disease-specific medical content
• Improve patient outcomes at the point of care
Target Audience:
This CME/CE program is intended for oncologists, obstetrician-gynecologists, radiologists, primary care clinicians, physician assistants, nurses, nurse practitioners, pharmacists, and other oncology healthcare team members that treat and care for patients with breast cancer.
Скрыть Показать больше...

Скриншоты

Breast Cancer [BC] Частые Вопросы

  • Приложение Breast Cancer [BC] бесплатное?

    Да, Breast Cancer [BC] полностью бесплатное и не содержит встроенных покупок или подписок.

  • Является ли Breast Cancer [BC] фейковым или мошенническим?

    Недостаточно отзывов для надежной оценки. Приложению нужно больше отзывов пользователей.

    Спасибо за ваш голос

  • Сколько стоит Breast Cancer [BC]?

    Приложение Breast Cancer [BC] бесплатное.

  • Сколько зарабатывает Breast Cancer [BC]?

    Чтобы получить оценку дохода приложения Breast Cancer [BC] и другие данные AppStore, вы можете зарегистрироваться на платформе мобильной аналитики AppTail.

Оценки пользователей
Приложение еще не оценено в Южно-Африканская Республика.
История оценок

Breast Cancer [BC] Отзывы Пользователей

Нет отзывов в Южно-Африканская Республика
Приложение пока не имеет отзывов в Южно-Африканская Республика.

Оценки

История позиций в топах
История рейтингов пока не доступна
Позиции в категории
Приложение еще не было в топах

Breast Cancer [BC] Конкуренты

Name
BCSC AdvancedBreastCancerRisk
Risk Calculator
Manual of Clinical Oncology
with Expert Recommentations
Cancer Pharmacology Manual
Anticancer Oncology Drug Guide
My Risk Breast Cancer
Find your breast cancer risk
Breast Cancer Club
Triple Negative Breast Cancer
Mammography Assistant
Breast Cancer Staging
ABC's of Breast Health
Breast Cancer Survivorship
Thrive HKU
BCSC InvasiveBreastCalculator
Risk Calculator

Breast Cancer [BC] Установки

30дн.

Breast Cancer [BC] Доход

30дн.

Breast Cancer [BC] Доходы и Загрузки

Получите ценные инсайты о производительности Breast Cancer [BC] с помощью нашей аналитики.
Зарегистрируйтесь сейчас, чтобы получить доступ к статистика загрузок и доходов и многому другому.

Информация о приложении

This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.